改进翻译:需要利用复杂的成性药物的临床前模型来加快物质使用治疗选择
Christa Corley1, Ashley Craig1, Safiyah Sadek1
1Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA.
Pharmacology, biochemistry, and behavior
|July 27, 2024
概括
临床前成模型需要更新,以更好地反映人类物质使用障碍 (SUD). 将先进的神经科学与改进的行为模型相结合,对于开发有效的SUD药物至关重要.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 成研究 研究成研究
背景情况:
- 存在了数十年的物质使用障碍 (SUD) 的临床前模型,包括被动暴露和自愿摄入.
- 目前FDA批准的SUD药物有效性有限,可能呈现性别差异,有护理差距.
- 现有的模型需要改进,以与药物使用的临床需求和流行病学趋势保持一致.
研究的目的:
- 提供当前和新型行为上模型的全面审查.
- 突出这些模型对SUDs临床经验的翻译价值.
- 确定改善SUDs药物开发管道的领域.
主要方法:
- 经常使用的和新的成行为模型的审查.
- 对临床SUD经验的翻译价值的分析.
- 探索神经科学技术,特别是大脑转录学,用于目标识别.
主要成果:
- 临床前模型需要更好地接近SUDs的临床经验.
- 毒品使用的流行病学趋势应该为临床前研究方向提供信息.
- 大脑转录组学的进步为识别新型治疗点提供了潜力.
结论:
- 改善行为模型和方法参数的选择是必不可少的.
- 尖端的神经科学技术,如转录学,对于推进SUD药物开发至关重要.
- 精细模型和先进的神经科学的结合方法将加速有效SUD治疗的发展.
相关概念视频
Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Drug Abuse and Addiction: Pharmacological Phenomena
457
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
457
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K


